HUMAN IMMUNODEFICIENCY VIRUS TYPE-2 IS A POTENT INHIBITOR OF HIV-1 VIRAL REPLICATION
US Application 08/153,117
Filed on 1993-11-15
Filed on 1993-11-15
ANTHRAX TOXIN FUSION PROTEINS AND RELATED METHODS
US Patent 5,677,274
Filed on 1993-06-25
Filed on 1993-06-25
ENCODING IgE RECEPTOR ALPHA-SUBUNIT OR FRAGMENT THEREOF
US Application 07/870,789
Filed on 1992-04-16
Filed on 1992-04-16
INHIBITION OF RETROVIRUS INFECTION
US Application 07/943,369
Filed on 1992-09-09
Filed on 1992-09-09
BETA-CYSTATHIONASE AND DERIVATIVES THEREOF
US Application 08/038,344
Filed on 1993-03-26
Filed on 1993-03-26
Anthrax Toxin Fusion Proteins and Uses Thereof
US Patent 5,591,631
Filed on 1993-02-12
Filed on 1993-02-12
RECOMBINANT ANTHRAX VACCINES
US Application 08/042,745
Filed on 1993-04-05
Filed on 1993-04-05
METHOD FOR SCREENING AN AGENT FOR ITS ABILITY TO PREVENT CELL TRANSFORMATION
US Patent 5,384,243
Filed on 1992-12-11
Filed on 1992-12-11